EP3347377
TSLP-bindandi mótefni og aðferðir til notkunar á mótefnunum
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
7.9.2016EP published:
17.2.2021EP application number:
16766396.2
EP translation filed:
29.4.2021Grant published:
15.5.2021EPO information:
European Patent Register
Max expiry date:
6.9.2036Expiry date:
6.9.2023
Title:
THYMIC STROMAL LYMPHOPOIETIN (TSLP)-BINDING ANTIBODIES AND METHODS OF USING THE ANTIBODIES
Timeline
Today
7.9.2016EP application
17.2.2021EP Publication
29.4.2021Translation submitted
15.5.2021Registration published
6.9.2023Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
RONDEAU, Jean-Michel ReneAddress:
4002 Basel, CH
Name:
EDWARDS, Matthew JohnAddress:
Horsham Sussex RH13 6BS, GB
Name:
MILLER, DanforthAddress:
San Carlos, California 94070, US
Name:
HUANG, DanielAddress:
San Carlos, California 94070, US
Name:
HEMMIG, ReneAddress:
4002 Basel, CH
Name:
KNOPF, Hans-PeterAddress:
4002 Basel, CH
Name:
GUPTA, KapilAddress:
Concord, Massachusetts 01742, US
Name:
VAN HEEKE, Gino AnselmusAddress:
Upper Beeding BN44 3HP, GB
Name:
HAUBST, NicoleAddress:
82152 Planegg, DE
Name:
ANDLAUER, BarbaraAddress:
82152 Planegg, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562216050 PDate:
9.9.2015Country:
US
Number:
201662342511 PDate:
27.5.2016Country:
US
Classification
Categories:
C07K 16/24, A61K 9/00, A61P 11/06, A61P 37/08
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 23.8.2021
Expires: 6.9.2022
Payer: Árnason Faktor ehf.
Number: 7
Paid: 30.8.2022
Expires: 6.9.2023
Payer: Árnason Faktor ehf.